Skip to content

Dimebon

DRUG18 trials

Sponsors

Medivation, Inc., Pfizer

Conditions

Alzheimer DiseaseAlzheimer's DiseaseHealthy VolunteersHepatic FailureHuntington DiseaseHuntington's Disease

Phase 1

Safety Study of the Novel Drug Dimebon to Treat Patients With Huntington's Disease
CompletedNCT00387270
Medivation, Inc.Huntington's Disease
Start: 2006-10-31End: 2007-03-31Updated: 2008-01-04
A Phase 1 Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF-01913539] In Japanese And Western Healthy Subjects
CompletedNCT00825084
PfizerAlzheimer's Disease, Huntington's Disease
Start: 2009-02-28End: 2009-05-31Updated: 2011-04-26
A Phase 1, Non-Randomized, Open-Label, Single-Dose Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF 01913539] In Subjects With Severely-Impaired And Normal Renal Function
CompletedNCT00824590
PfizerAlzheimer's Disease, Huntington's Disease
Start: 2009-02-28End: 2009-10-31Updated: 2009-12-30
A Phase 1, Randomized, Open-Label, Two-Way Crossover Study To Evaluate The Steady-State Effect Of Dimebon (PF 01913539) On The Single-Dose Pharmacokinetics And Pharmacodynamics Of Warfarin In Healthy Subjects
CompletedNCT00827034
PfizerAlzheimer's Disease, Huntington's Disease
Start: 2009-02-28End: 2009-04-30Updated: 2018-10-16
Safety and Tolerability of Dimebon in Patients on Memantine, and Memantine Plus Donepezil
CompletedNCT00829816
Medivation, Inc.Alzheimer's Disease
Start: 2008-12-31End: 2010-08-31Updated: 2015-11-10
Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [Pf-01913539] In Subjects With Hepatic Impairment And Normal Hepatic Function
CompletedNCT00831532
PfizerHepatic Failure
Start: 2009-02-28End: 2009-08-31Updated: 2009-09-16
Dimebon (PF-01913539)-Digoxin Drug-Drug Interaction Study In Healthy Subjects
CompletedNCT00831506
PfizerAlzheimer Disease, Huntington Disease
Start: 2009-02-28End: 2009-05-31Updated: 2009-06-12
A Phase 1 Trial To Assess The Safety And Pharmacokinetics Of Single, Ascending, Oral Doses Of Dimebon In Healthy Adults
CompletedNCT00907322
PfizerHealthy Volunteers
Start: 2009-06-30End: 2009-07-31Updated: 2009-07-22
A Study To Evaluate The Abuse Potential Of Single Oral Doses Of Dimebon (Latrepirdine) In Healthy Recreational Polydrug Users
CompletedNCT00975481
PfizerAlzheimer's Disease, Huntington's Disease
Start: 2009-10-31End: 2010-02-28Updated: 2013-04-02

Phase 2

Phase 3

Related Papers